Series A Funding
Biofidelity Raises $23M in Series A+ Financing Led by Octopus Ventures to Launch ASPYRE Technology
Biofidelity
PR-M02-22-04Feb 07, 2022
Cancer and Neurodegenerative Diseases
Leveraging the Cell Cytoskeleton for the Treatment of Cancer and Neurodegenerative Diseases
Maurice Zauderer, Ph.D.
Vaccinex, Inc.
PAP-Q2-20-CL-024Jul 01, 2020